1	Differences	difference	_	_	_	_	_	_	_
2	in	in	_	_	_	_	_	_	_
3	phosphorylation	phosphorylation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	IL-2R	il-2r	_	_	_	_	_	_	_
7	associated	associated	_	_	_	_	_	_	_
8	JAK/STAT	JAK/STAT	_	_	_	_	_	_	_
9	proteins	protein	_	_	_	_	_	_	_
10	between	between	_	_	_	_	_	_	_
11	HTLV-I(+)	htlv-i(+)	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	IL-2-independent	il-2-independent	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	IL-2-dependent	il-2-dependent	_	_	_	_	_	_	_
16	cell	cell	_	_	_	_	_	_	_
17	lines	line	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	uncultured	uncultured	_	_	_	_	_	_	_
20	leukemic	leukemic	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	from	from	_	_	_	_	_	_	_
23	patients	patient	_	_	_	_	_	_	_
24	with	with	_	_	_	_	_	_	_
25	adult	adult	_	_	_	_	_	_	_
26	T-cell	t-cell	_	_	_	_	_	_	_
27	lymphoma/leukemia	lymphoma/leukemia	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	determine	determine	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	status	status	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	IL-2R-associated	il-2r-associated	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	Jak/STAT	Jak/STAT	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	pathway	pathway	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	HTLV-I	HTLV-I	_	_	_	_	_	_	_
15	infected	infected	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	we	we	_	_	_	_	_	_	_
19	examined	examine	_	_	_	_	_	_	_
20	tyrosine	tyrosine	_	_	_	_	_	_	_
21	phosphorylation	phosphorylation	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	Jak3	Jak3	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	STAT3	STAT3	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	STAT5	stat5	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	several	several	_	_	_	_	_	_	_
31	HTLV-I(+)	htlv-i(+)	_	_	_	_	_	_	_
32	T-cell	t-cell	_	_	_	_	_	_	_
33	lines	line	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	in	in	_	_	_	_	_	_	_
36	uncultured	uncultured	_	_	_	_	_	_	_
37	leukemic	leukemic	_	_	_	_	_	_	_
38	T	t	_	_	_	_	_	_	_
39	cells	cell	_	_	_	_	_	_	_
40	isolated	isolate	_	_	_	_	_	_	_
41	from	from	_	_	_	_	_	_	_
42	patients	patient	_	_	_	_	_	_	_
43	with	with	_	_	_	_	_	_	_
44	adult	adult	_	_	_	_	_	_	_
45	T-cell	t-cell	_	_	_	_	_	_	_
46	lymphoma/leukemia	lymphoma/leukemia	_	_	_	_	_	_	_
47	(	(	_	_	_	_	_	_	_
48	ATLL	ATLL	_	_	_	_	_	_	_
49	)	)	_	_	_	_	_	_	_
50	.	.	_	_	_	_	_	_	_

1	Constitutive	constitutive	_	_	_	_	_	_	_
2	basal	basal	_	_	_	_	_	_	_
3	phosphorylation	phosphorylation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	Jak3	Jak3	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	usually	usually	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	STAT3	STAT3	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	STAT5	STAT5	_	_	_	_	_	_	_
13	was	be	_	_	_	_	_	_	_
14	detected	detect	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	all	all	_	_	_	_	_	_	_
17	four	four	_	_	_	_	_	_	_
18	IL-2-independent	il-2-independent	_	_	_	_	_	_	_
19	cell	cell	_	_	_	_	_	_	_
20	lines	line	_	_	_	_	_	_	_
21	tested	test	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	but	but	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	none	none	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	three	three	_	_	_	_	_	_	_
29	IL-2-dependent	il-2-dependent	_	_	_	_	_	_	_
30	cell	cell	_	_	_	_	_	_	_
31	lines	line	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Similarly	similarly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	there	there	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	no	no	_	_	_	_	_	_	_
6	detectable	detectable	_	_	_	_	_	_	_
7	basal	basal	_	_	_	_	_	_	_
8	phosphorylation	phosphorylation	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	Jak3	Jak3	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	STAT5	STAT5	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	leukemic	leukemic	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	from	from	_	_	_	_	_	_	_
18	ATLL	ATLL	_	_	_	_	_	_	_
19	patients	patient	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	0/8	0/8	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	0/3	0/3	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	respectively	respectively	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	stimulation	stimulation	_	_	_	_	_	_	_
4	with	with	_	_	_	_	_	_	_
5	IL-2	il-2	_	_	_	_	_	_	_
6	resulted	result	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	Jak3	Jak3	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	STAT5	STAT5	_	_	_	_	_	_	_
11	phosphorylation	phosphorylation	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	both	both	_	_	_	_	_	_	_
14	leukemic	leukemic	_	_	_	_	_	_	_
15	ATLL	atll	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	IL-2-dependent	il-2-dependent	_	_	_	_	_	_	_
19	lines	line	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	expression	expression	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	SHP-1	shp-1	_	_	_	_	_	_	_
6	phosphatase	phosphatase	_	_	_	_	_	_	_
7	which	which	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	negative	negative	_	_	_	_	_	_	_
11	regulator	regulator	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	cytokine	cytokine	_	_	_	_	_	_	_
14	receptor	receptor	_	_	_	_	_	_	_
15	signaling	signaling	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	was	be	_	_	_	_	_	_	_
18	lost	lose	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	most	most	_	_	_	_	_	_	_
21	IL-2	il-2	_	_	_	_	_	_	_
22	independent	independent	_	_	_	_	_	_	_
23	cell	cell	_	_	_	_	_	_	_
24	lines	line	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	3/4	3/4	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	but	but	_	_	_	_	_	_	_
29	not	not	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	leukemic	leukemic	_	_	_	_	_	_	_
33	ATLL	atll	_	_	_	_	_	_	_
34	cells	cell	_	_	_	_	_	_	_
35	(	(	_	_	_	_	_	_	_
36	0/3).	0/3).	_	_	_	_	_	_	_
37	Finally	finally	_	_	_	_	_	_	_
38	,	,	_	_	_	_	_	_	_
39	the	the	_	_	_	_	_	_	_
40	HTLV-I(+)	htlv-i(+)	_	_	_	_	_	_	_
41	T-cell	t-cell	_	_	_	_	_	_	_
42	lines	line	_	_	_	_	_	_	_
43	(	(	_	_	_	_	_	_	_
44	313	313	_	_	_	_	_	_	_
45	)	)	_	_	_	_	_	_	_
46	but	but	_	_	_	_	_	_	_
47	not	not	_	_	_	_	_	_	_
48	the	the	_	_	_	_	_	_	_
49	control	control	_	_	_	_	_	_	_
50	,	,	_	_	_	_	_	_	_
51	HTLV-I(-)	htlv-i(-)	_	_	_	_	_	_	_
52	T-cell	T-cell	_	_	_	_	_	_	_
53	lines	line	_	_	_	_	_	_	_
54	were	be	_	_	_	_	_	_	_
55	resistant	resistant	_	_	_	_	_	_	_
56	to	to	_	_	_	_	_	_	_
57	rapamycin	rapamycin	_	_	_	_	_	_	_
58	and	and	_	_	_	_	_	_	_
59	its	its	_	_	_	_	_	_	_
60	novel	novel	_	_	_	_	_	_	_
61	analog	analog	_	_	_	_	_	_	_
62	RAD	RAD	_	_	_	_	_	_	_
63	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	conclude	conclude	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	1	1	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	HTLV-I	HTLV-I	_	_	_	_	_	_	_
8	infection	infection	_	_	_	_	_	_	_
9	per	per	_	_	_	_	_	_	_
10	se	se	_	_	_	_	_	_	_
11	does	do	_	_	_	_	_	_	_
12	not	not	_	_	_	_	_	_	_
13	result	result	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	constitutive	constitutive	_	_	_	_	_	_	_
17	phosphorylation	phosphorylation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	Jak3	jak3	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	STAT3	STAT3	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	STAT5	stat5	_	_	_	_	_	_	_
26	proteins	protein	_	_	_	_	_	_	_
27	;	;	_	_	_	_	_	_	_
28	(	(	_	_	_	_	_	_	_
29	2	2	_	_	_	_	_	_	_
30	)	)	_	_	_	_	_	_	_
31	malignant	malignant	_	_	_	_	_	_	_
32	transformation	transformation	_	_	_	_	_	_	_
33	in	in	_	_	_	_	_	_	_
34	at	at	_	_	_	_	_	_	_
35	least	least	_	_	_	_	_	_	_
36	some	some	_	_	_	_	_	_	_
37	cases	case	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	ATLL	ATLL	_	_	_	_	_	_	_
40	does	do	_	_	_	_	_	_	_
41	not	not	_	_	_	_	_	_	_
42	require	require	_	_	_	_	_	_	_
43	the	the	_	_	_	_	_	_	_
44	constitutive	constitutive	_	_	_	_	_	_	_
45	,	,	_	_	_	_	_	_	_
46	but	but	_	_	_	_	_	_	_
47	may	may	_	_	_	_	_	_	_
48	require	require	_	_	_	_	_	_	_
49	IL-2-induced	il-2-induced	_	_	_	_	_	_	_
50	,	,	_	_	_	_	_	_	_
51	activation	activation	_	_	_	_	_	_	_
52	of	of	_	_	_	_	_	_	_
53	the	the	_	_	_	_	_	_	_
54	IL-2R	IL-2R	_	_	_	_	_	_	_
55	Jak/STAT	Jak/STAT	_	_	_	_	_	_	_
56	pathway	pathway	_	_	_	_	_	_	_
57	;	;	_	_	_	_	_	_	_
58	and	and	_	_	_	_	_	_	_
59	(	(	_	_	_	_	_	_	_
60	3	3	_	_	_	_	_	_	_
61	)	)	_	_	_	_	_	_	_
62	there	there	_	_	_	_	_	_	_
63	are	be	_	_	_	_	_	_	_
64	major	major	_	_	_	_	_	_	_
65	differences	difference	_	_	_	_	_	_	_
66	in	in	_	_	_	_	_	_	_
67	T-cell	t-cell	_	_	_	_	_	_	_
68	immortalization	immortalization	_	_	_	_	_	_	_
69	mechanism(s)	mechanism(s)	_	_	_	_	_	_	_
70	which	which	_	_	_	_	_	_	_
71	appear	appear	_	_	_	_	_	_	_
72	to	to	_	_	_	_	_	_	_
73	involve	involve	_	_	_	_	_	_	_
74	SHP-1	shp-1	_	_	_	_	_	_	_
75	and	and	_	_	_	_	_	_	_
76	target	target	_	_	_	_	_	_	_
77	molecules	molecule	_	_	_	_	_	_	_
78	for	for	_	_	_	_	_	_	_
79	rapamycin	rapamycin	_	_	_	_	_	_	_
80	and	and	_	_	_	_	_	_	_
81	RAD	RAD	_	_	_	_	_	_	_
82	.	.	_	_	_	_	_	_	_

